Literature DB >> 4171718

The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.

W Fox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4171718     DOI： 10.1164/arrd.1968.97.5.767

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  12 in total

1.  New drug regimens in the treatment of tuberculosis.

Authors:  E Wolinsky
Journal:  Bull N Y Acad Med       Date:  1975-10

Review 2.  Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review.

Authors:  M Zierski
Journal:  Lung       Date:  1977       Impact factor: 2.584

3.  A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.

Authors: 
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

Review 5.  New trends in the chemotherapy of tuberculosis--current aspects.

Authors:  M Zierski
Journal:  Pneumonologie       Date:  1974-06-14

Review 6.  General considerations in intermittent drug therapy of pulmonary tuberculosis.

Authors:  W Fox
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

Review 7.  [Results of chemotherapy in tuberculosis].

Authors:  E Jancik
Journal:  Pneumonologie       Date:  1971

8.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

9.  [New paths of chemotherapy].

Authors:  G Urbanczik
Journal:  Pneumonologie       Date:  1971

10.  A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis.

Authors: 
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.